We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

“BridgIT” Identifies Candidate Genes and Catalyzing Proteins for Orphan and Novel Enzyme Reactions

News   Mar 28, 2019 | Original story from EPFL

 
“BridgIT” Identifies Candidate Genes and Catalyzing Proteins for Orphan and Novel Enzyme Reactions

The computational tool BridgIT assigns genes and proteins to orphan and novel hypothetical reactions by studying the reactive sight of an enzymatic reaction as well as the surrounding atoms. Credit: EPFL

 
 
Advertisement
 

RELATED ARTICLES

Drug That Targets Challenging Cancer Mutation Could Treat Several Tumor Types

News

A new clinical trial shows a novel drug designed to counter the effects of an important cancer mutation could be effective against a range of tumor types including lung and gynecological cancers.

READ MORE

Turning the Virus’ RBD Into a Nanoparticle an Appealing Approach for COVID-19 Vaccine

News

A University at Buffalo-led research team has discovered a technique that could help increase the effectiveness of vaccines against the novel coronavirus, the virus that causes COVID-19.

READ MORE

Deep Learning Model Helps Drug Developers Target SARS-CoV-2's Main Protease

News

Researchers have deployed a machine learning model to help drug developers on their most promising leads for attacking one of the virus’ most compelling targets –SARS-CoV-2's main protease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE